Capitol Street is pleased to host periodic webinars featuring luminaries, and respected industry leaders throughout the year.
We welcome you to replay these session recordings using the password provided, and look forward to you joining a live session in the future.
Fall Outlook
The Capitol Street Team discusses the the likely healthcare agenda as Congress returns from the August recess. Topics include APTCs, telehealth, community health center funding, clinical lab pay (PAMA moratorium), Medicaid DSH, rural hospital extenders, and PBM reform. Use password: Am.brc43
2025 Health Industry Outlook Report
The 38 page slide deck download includes must-pass bills, healthcare themes, election outlook, catalysts, likely headlines, and industry impacts by sector. Capitol Street’s founder Ipsita Smolinski and the Capitol Street team thoroughly discuss the slide presentation. Use password: !o3^G3!A
Medicare Advantage in 2025: What Now?
America’s Health Insurance Plans’ (AHIP) Mark Hamelburg discusses Medicare Advantage in 2025: What Now? CMS dealt a blow to Medicare Advantage plans and value based care providers with a nearly identical cut as proposed to pay for plans in 2025. Mark discusses AHIP’s take on what happened, why, winners & losers, as well as what the trade associations will be doing to message the impact on services and beneficiaries. Use password: by^Y50PY
MA Final Rate Deep Dive
Capitol Street’s founder Ipsita Smolinski and Senior Policy Advisor Tom Kornfield discuss the Final 2025 MA Rates. Throughout this conversation, they discuss similarities and differences between the proposed rates and the final rates, which feature a negative impact on MA plans & VBC providers. Additionally, they spoke about the new Part D risk model, a separate MA “clean up rule”, v28, Stars and FFS growth rates and Part C and D normalization. Use password: e6$@p*UK
Unpacking Medicare Advantage 2025 Rates & Policies
Capitol Street’s founder Ipsita Smolinski and Senior Policy Advisor Tom Kornfield discuss the recent 2025 MA Rate Notice and Part D Call letter from CMS. Throughout this conversation, they discuss growth rate, Stars, normalization, v28, coding intensity, and other policies that came from the release. Additionally, they talk through other key points on Part D, like CMS’ guidance to restructure the drug benefit to account for a new $2,000 OOP cap along with new manufacturer and insurer liabilities in the catastrophic phase (per IRA). They also touch on MedPAC analyses, transparency RFI, and incremental guidance (2025) on supplemental benefits, D-SNP, prior authorization, and marketing guidelines. Use password: E9x0$Hht
Colorado PDAB Model Outlook
Capitol Street talks with guest speaker Katelin Lucariello, PhRMA’s representative on the ground in Colorado. Katelin shares insights on the State of Colorado Prescription Drug Affordability Review Board (PDAB) and its affordability reviews for Genvoya (GILD), Enbrel (AMGN), & Trikafta (VRTX). Other inputs and factors such as the implementation of the IRA at the federal level are discussed. Use password: u&%Ke5vF
Summer Virtual Keynote Policy Series
PBM: Policy and Business Model Outlook
Capitol Street talks with guest speaker Stephanie Quinn to discuss ACO REACH progress and pay reforms overall as CMMI strives to reach its 2030 goal, as well as other models (oncology care, pending drug models impacting cell & gene therapy). Use password: R9xj!KkA
Summer Virtual Keynote Policy Series
AI & Medicare Coverage: What’s Included and Not? How Policy is Moving Ahead
Capitol Street joins guest speaker Jill Rathbun in discussing that while AI is advancing, outcomes have not been all roses. Sustained adoption of AI through the current reimbursement framework may be challenging in a fee-for-service (FFS) environment, but as value-based payment models evolve and adapt, AI is posed to become an even more valuable tool for healthcare systems and individual providers. Use password: #zE@3I*C
